Advertisement
Advertisement
Trending on OncLive
1
Duvelisib Plus Nivolumab Elicits Responses, but imAEs Limit Dosing in Pretreated CTCL
2
FDA Approves Prefilled Pen for Ropeginterferon Alfa-2b in Polycythemia Vera
3
Mogamulizumab Improves Patient-Reported Symptoms and HRQOL in Mycosis Fungoides/Sézary Syndrome
4
Extended Teclistamab/Daratumumab Indication Approaches EU Approval in R/R Multiple Myeloma
5